Published in Am J Geriatr Psychiatry on December 01, 2011
Depression after stroke and risk of mortality: a systematic review and meta-analysis. Stroke Res Treat (2013) 1.21
Management of patients with stroke: is it time to expand treatment options? Ann Neurol (2013) 0.91
Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis. J Neurol (2014) 0.89
Citalopram enhances neurovascular regeneration and sensorimotor functional recovery after ischemic stroke in mice. Neuroscience (2013) 0.83
Using antidepressants and the risk of stroke recurrence: report from a national representative cohort study. BMC Neurol (2015) 0.83
Pharmacological therapies in post stroke recovery: recommendations for future clinical trials. J Neurol (2013) 0.82
Pharmacologic approaches to cerebral aging and neuroplasticity: insights from the stroke model. Dialogues Clin Neurosci (2013) 0.81
Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence. Brain Behav (2015) 0.81
Increased frequency of first-episode poststroke depression after discontinuation of escitalopram. Stroke (2011) 0.81
Fluoxetine Maintains a State of Heightened Responsiveness to Motor Training Early After Stroke in a Mouse Model. Stroke (2015) 0.80
Exploring new frontiers in neuropsychopharmacology: SSRIs for stroke. Indian J Psychiatry (2011) 0.75
The relationship between frontal lobe lesions, course of post-stroke depression, and 1-year prognosis in patients with first-ever ischemic stroke. PLoS One (2014) 0.75
Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial. Trials (2013) 0.75
Rehabilitation of Motor Function after Stroke: A Multiple Systematic Review Focused on Techniques to Stimulate Upper Extremity Recovery. Front Hum Neurosci (2016) 0.75
Do antidepressants improve recovery from neurologic illness? Am J Geriatr Psychiatry (2011) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
Interobserver agreement for the assessment of handicap in stroke patients. Stroke (1988) 20.14
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (2003) 16.14
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci (2000) 9.12
Recovery of motor function after stroke. Stroke (1988) 4.31
Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry (1993) 3.34
The cellular neurobiology of depression. Nat Med (2001) 3.19
Tumor necrosis factor-alpha mediates one component of competitive, experience-dependent plasticity in developing visual cortex. Neuron (2008) 3.07
Normative data and screening power of a shortened version of the Token Test. Cortex (1978) 2.45
Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry (2000) 2.12
Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke (1996) 1.84
Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology (2004) 1.77
A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol (2009) 1.70
The pilot Stroke Data Bank: definition, design, and data. Stroke (1984) 1.67
A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation. Stroke (1984) 1.35
Mood change following left hemispheric brain injury. Ann Neurol (1981) 1.26
The neuropsychiatry of stroke. Psychosomatics (2000) 1.25
5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Res (2002) 1.24
Inter-rater agreement and stability of functional assessment in the community-based elderly. Arch Phys Med Rehabil (1994) 1.11
Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol (2007) 1.11
Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke (2000) 1.10
Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures. Int J Neuropsychopharmacol (2005) 1.06
Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry (1999) 0.99
The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study. J Nerv Ment Dis (2001) 0.90
Charting patients' course: a comparison of statistics used to summarize patient course in longitudinal and repeated measures studies. J Psychiatr Res (2000) 0.89
One-year follow-Up in stroke patients discharged from rehabilitation hospital. Cerebrovasc Dis (2000) 0.89
Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med (2011) 7.16
Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA (2008) 5.96
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA (2011) 4.46
Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke (2003) 4.13
Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry (2003) 3.41
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
Eliminating tobacco-related health disparities: directions for future research. Am J Public Health (2004) 2.50
Risk factors associated with aortic and carotid intima-media thickness in adolescents and young adults: the Muscatine Offspring Study. J Am Coll Cardiol (2009) 1.91
Major depression following traumatic brain injury. Arch Gen Psychiatry (2004) 1.88
Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation (2014) 1.81
Brainstem involvement in hypertensive encephalopathy: clinical and radiological findings. Neurology (2004) 1.80
Surgical results of the Carotid Occlusion Surgery Study. J Neurosurg (2012) 1.73
The types of neurological deficits might not justify withholding treatment in patients with low total National Institutes of Health Stroke Scale scores. Stroke (2012) 1.70
Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol (2013) 1.62
Lower stroke risk with lower blood pressure in hemodynamic cerebral ischemia. Neurology (2014) 1.59
The marketing of menthol cigarettes in the United States: populations, messages, and channels. Nicotine Tob Res (2004) 1.54
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia. Leuk Lymphoma (2011) 1.51
The construct of minor and major depression in Alzheimer's disease. Am J Psychiatry (2005) 1.43
Increased risk of alcohol and drug use among children from deployed military families. Addiction (2013) 1.42
Clinical correlates of aggressive behavior after traumatic brain injury. J Neuropsychiatry Clin Neurosci (2003) 1.34
White matter volume and cognitive dysfunction in early Huntington's disease. Cogn Behav Neurol (2005) 1.34
Rural-urban differences in acute stroke management practices: a modifiable disparity. Arch Neurol (2008) 1.33
The cerebellum and emotional experience. Neuropsychologia (2006) 1.31
Apathy following stroke. Can J Psychiatry (2010) 1.26
The Carotid Occlusion Surgery Study. Neurosurg Focus (2003) 1.21
Association between a leukotriene C4 synthase gene promoter polymorphism and coronary artery calcium in young women: the Muscatine Study. Arterioscler Thromb Vasc Biol (2006) 1.19
Defining and diagnosing involuntary emotional expression disorder. CNS Spectr (2006) 1.12
Cohort Profile: the international childhood cardiovascular cohort (i3C) consortium. Int J Epidemiol (2012) 1.10
Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial. Stroke (2008) 1.09
Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry (2008) 1.08
Neuropsychological performance is associated with vascular function in patients with atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol (2006) 1.05
Blood vessel function and cognition in elderly patients with atherosclerosis. Stroke (2004) 1.05
The effect of early versus late antidepressant treatment on physical impairment associated with poststroke depression: is there a time-related therapeutic window? J Nerv Ment Dis (2003) 1.05
Menthol cigarettes: setting the research agenda. Nicotine Tob Res (2004) 1.04
Unawareness of illness in neuropsychiatric disorders: phenomenological certainty versus etiopathogenic vagueness. Neuroscientist (2007) 1.03
Moyamoya-induced paroxysmal dyskinesia. Mov Disord (2003) 1.01
Patent foramen ovale: paradoxical embolism and paradoxical data. Mayo Clin Proc (2004) 1.00
Aging, grey matter, and blood flow in the anterior cingulate cortex. Neuroimage (2007) 1.00
Cerebral arteriolar thromboembolism in idiopathic hypereosinophilic syndrome. Arch Neurol (2009) 1.00
Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry (2010) 0.99
Early recovery after cerebral ischemia risk of subsequent neurological deterioration. Ann Neurol (2003) 0.99
Effect of antidepressant therapy on executive function after stroke. Br J Psychiatry (2007) 0.98
The frequency, clinical correlates, and mechanism of anosognosia after stroke. Can J Psychiatry (2010) 0.98
The construct of generalized anxiety disorder in Alzheimer disease. Am J Geriatr Psychiatry (2007) 0.98
Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biol Psychiatry (2004) 0.97
Pneumocephalus after air travel. Neurology (2004) 0.97
Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression. Am J Psychiatry (2003) 0.97
Extending acute trials to remote populations: a pilot study during interhospital helicopter transfer. Stroke (2009) 0.96
Nondysphoric depression following stroke. J Neuropsychiatry Clin Neurosci (2008) 0.95
Alcohol misuse and mood disorders following traumatic brain injury. Arch Gen Psychiatry (2005) 0.94
Toward fully automated processing of dynamic susceptibility contrast perfusion MRI for acute ischemic cerebral stroke. Comput Methods Programs Biomed (2010) 0.93
In vivo proton magnetic resonance spectroscopy in patients with mood disorders: a technically oriented review. J Magn Reson Imaging (2007) 0.92
Neurological aspects of biological and chemical terrorism: a review for neurologists. Arch Neurol (2003) 0.92
Response of emotional unawareness after stroke to antidepressant treatment. Am J Geriatr Psychiatry (2006) 0.92
Pathological laughing and crying following traumatic brain injury. J Neuropsychiatry Clin Neurosci (2004) 0.91
Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke. Curr Neurovasc Res (2009) 0.90
Can we predict early recurrence in acute stroke? Cerebrovasc Dis (2004) 0.90
Diagnostic criteria for depression in Parkinson's disease: a study of symptom patterns using latent class analysis. Mov Disord (2011) 0.89
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Advocacy Writing Group. Circulation (2005) 0.89
Aging and alexithymia: association with reduced right rostral cingulate volume. Am J Geriatr Psychiatry (2008) 0.89
Mood disorders following traumatic brain injury. Int Rev Psychiatry (2003) 0.88
A validation study of depressive syndromes in Parkinson's disease. Mov Disord (2008) 0.88
Neural bases of dysphoria in early Huntington's disease. Psychiatry Res (2008) 0.88
Regional cerebral blood flow changes during visually induced subjective sadness in healthy elderly persons. J Neuropsychiatry Clin Neurosci (2003) 0.87
Therapist adherence to a motivational-interviewing intervention improves treatment entry for substance-misusing adolescents with low problem perception. J Stud Alcohol Drugs (2009) 0.86
Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials. Am J Geriatr Psychiatry (2003) 0.86
Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis (2002) 0.86
Phenomenological characteristics of poststroke depression: early- versus late-onset. Am J Geriatr Psychiatry (2002) 0.85
Double-blind treatment of apathy in patients with poststroke depression using nefiracetam. J Neuropsychiatry Clin Neurosci (2009) 0.84
Prevention of poststroke apathy using escitalopram or problem-solving therapy. Am J Geriatr Psychiatry (2013) 0.84
Incident apathy during the first year after stroke and its effect on physical and cognitive recovery. Am J Geriatr Psychiatry (2013) 0.84
Slow progressive acceptance of intravenous thrombolysis for patients with stroke by rural primary care physicians. Arch Neurol (2007) 0.84
Is family history of depression a risk factor for poststroke depression? Meta-analysis. Am J Geriatr Psychiatry (2009) 0.84
Improving prediction of outcome in "good grade" subarachnoid hemorrhage. Neurosurgery (2007) 0.83
Responses to S. Leonard Syme's essay. Prev Chronic Dis (2004) 0.83
Phenomenology and clinical correlates of delusions in Alzheimer disease. Am J Geriatr Psychiatry (2006) 0.83
Vascular depression and poststroke depression: where do we go from here? Am J Geriatr Psychiatry (2005) 0.82
Increased frequency of first-episode poststroke depression after discontinuation of escitalopram. Stroke (2011) 0.81
Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression. J Neuropsychiatry Clin Neurosci (2010) 0.81
Reassessing the link between herpes zoster ophthalmicus and stroke. Expert Rev Anti Infect Ther (2014) 0.81